Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation

INTRODUCTION: A growing body of evidence suggests that specific, naturally occurring gut bacteria are under-represented in the intestinal tracts of subjects with type 2 diabetes (T2D) and that their functions, like gut barrier stability and butyrate production, are important to glucose and insulin h...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMJ Open Diabetes Res Care
Auteurs principaux: Perraudeau, Fanny, McMurdie, Paul, Bullard, James, Cheng, Andrew, Cutcliffe, Colleen, Deo, Achal, Eid, John, Gines, Jessica, Iyer, Mohan, Justice, Nicholas, Loo, Wesley T, Nemchek, Madeleine, Schicklberger, Marcus, Souza, Michael, Stoneburner, Brendon, Tyagi, Surabhi, Kolterman, Orville
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2020
Sujets:
Emerging Technologies, Pharmacology and Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368581/
https://ncbi.nlm.nih.gov/pubmed/32675291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2020-001319
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires